| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6493e075b586cf5568b69116429349a8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
2017-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d9efda56ac5ee623b0b506e35d5a1cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2d540f962394499bbe9b19fc30ddc43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8e64cd0fecdf6eeae00e13f641614d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4735e5eb9efda65632cd6c12775cb125 |
| publicationDate |
2019-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112019012573-A2 |
| titleOfInvention |
transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| abstract |
The present invention relates to a transdermal therapeutic system (tts) for transdermal administration of asenapine comprising a self-adhesive layered structure comprising a therapeutically effective amount of asenapine, said self-adhesive layered structure comprising: a) a backing layer; (b) an asenapine-containing layer comprising: 1. asenapine in free base form; and 2. a polymer selected from the group consisting of polysiloxanes and polyisobutylenes in an amount greater than 50% by weight based on the total weight of the asenapine-containing layer; and c) optionally an additional skin contact layer. |
| priorityDate |
2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |